Nesrin Öcal

Nesrin Öcal

Auto-generated profile, based on publicly available information

Nesrin Öcal

Department of Pulmonary Medicine, University of Health Sciences Gulhane School of Medicine Ankara, Türkiye

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 May 2023 in Respiratory Investigation
Verified
Journal Article
Closed access
ACAykut Cilli
Aykut Cilli
NONesrin Ocal
Nesrin Ocal
FUFatih Uzer
Fatih Uzer
FCFunda Coskun
Funda Coskun
CSCan Sevinc
Can Sevinc
IHIsmail Hanta
Ismail Hanta

9 June 2021 in International Journal Of Clinical Practice
Verified
Journal Article
Closed access
PDF file
NDNilgün Yılmaz Demirci
Nilgün Yılmaz Demirci
ADASİYE UĞRAŞ DİKMEN
ASİYE UĞRAŞ DİKMEN
CTCantürk Taşçı
Cantürk Taşçı
DDDeniz Doğan
Deniz Doğan
YAYakup Arslan
Yakup Arslan
AYAYDIN YILMAZ
AYDIN YILMAZ

5 December 2024 in Irish Journal of Medical Science (1971 -)
Verified
Journal Article
Closed access
PDF file
ETEmre Tekgoz
Emre Tekgoz
SCSeda Yurumez Colak
Seda Yurumez Colak
EGEzgi Cimen Gunes
Ezgi Cimen Gunes
NONesrin Ocal
Nesrin Ocal
MCMuhammet Cinar
Muhammet Cinar
SYSedat YILMAZ
Sedat YILMAZ

9 June 2021 in International Journal Of Clinical Practice
Verified
Journal Article
Open access
PDF file
YAYakup Arslan
Yakup Arslan
DDDeniz Dogan
Deniz Dogan
NONesrin Ocal
Nesrin Ocal
AKAlperen Koc
Alperen Koc
TATunahan Ayaz
Tunahan Ayaz
HKHakan Kayir
Hakan Kayir
Objective Coronavirus disease 2019 (COVID-19) is an emerging, fast-spreading, highly mortal and worldwide infectious disease. The pulmonary system was defined as the main target of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), but the mortality concept of this disease presented with more severe and systemic disease. The present study investigated the relationship between the patient characteristics at the initial hospital administration and fatality in COVID-19 patients. Methods In this retrospective and comparative cohort study, all the 767 hospitalised COVID-19 patients, treated between 18 March and 15 May 2020 in the Covid Clinics of Gulhane Training and Research Hospital in Ankara, Turkey, were evaluated. Results The fatality rate was significantly increased in patients with any comorbid disease except asthma. The initial laboratory test results indicated highly significant differences according to the patient's outcome. A multifactor logistic regression analysis was performed to calculate the adjusted odds ratios for predicting patient outcomes. Being older than 60 years increased the death risk with an adjusted OR of 7.2 (95% CI: 2.23-23.51; P = .001). The presence of a cancer and the extended duration of intensive care unit treatment were other significant risk factors for nonsurvival. Azithromycin treatment was determined as significantly reduced the death ratio in these patients (P = .002). Conclusion It was revealed that being older than 60 years, presence of a cancer and extended duration of ICU treatment were the major risk factors for predicting fatality rate in hospitalised COVID-19 patients.

14 June 2021 in Flora the Journal of Infectious Diseases and Clinical Microbiology
Verified
Journal Article
Closed access
MFMine Filiz
Mine Filiz
GYGülden Yılmaz
Gülden Yılmaz
GFGonca Fidan
Gonca Fidan
SKSümeyye Köşger
Sümeyye Köşger
EKEkin Kadıoğlu
Ekin Kadıoğlu
CTCantürk Taşçı
Cantürk Taşçı

9 March 2024 in Clinical Rheumatology
Verified
Journal Article
Closed access
PDF file
SCSeda Colak
Seda Colak
ETEmre Tekgoz
Emre Tekgoz
EGEzgi Cimen Gunes
Ezgi Cimen Gunes
NONesrin Ocal
Nesrin Ocal
DDDeniz Dogan
Deniz Dogan
SYSedat YILMAZ
Sedat YILMAZ